Evaluation of the prognostic and predictive value of HER family mRNA expression in high-risk early breast cancer: a Hellenic Cooperative Oncology Group (HeCOG) study.
about
WW domain containing E3 ubiquitin protein ligase 1 targets the full-length ErbB4 for ubiquitin-mediated degradation in breast cancerTargeting of erbB3 receptor to overcome resistance in cancer treatmentBiomarkers of benefit from cetuximab-based therapy in metastatic colorectal cancer: interaction of EGFR ligand expression with RAS/RAF, PIK3CA genotypes.Nuclear HER4 mediates acquired resistance to trastuzumab and is associated with poor outcome in HER2 positive breast cancer.Inverse regulation of EGFR/HER1 and HER2-4 in normal and malignant human breast tissue.MMP9 but Not EGFR, MET, ERCC1, P16, and P-53 Is Associated with Response to Concomitant Radiotherapy, Cetuximab, and Weekly Cisplatin in Patients with Locally Advanced Head and Neck Cancer.Genetically dependent ERBB3 expression modulates antigen presenting cell function and type 1 diabetes risk.ERBB4 promoter polymorphism is associated with poor distant disease-free survival in high-risk early breast cancerSTAT-Related Profiles Are Associated with Patient Response to Targeted Treatments in Locally Advanced SCCHN.The effect of epiregulin on epidermal growth factor receptor expression and proliferation of oral squamous cell carcinoma cell lines.Evaluation of the prognostic significance of HER family mRNA expression in high-risk early breast cancer: a Hellenic Cooperative Oncology Group (HeCOG) validation study.HER2 and TOP2A in high-risk early breast cancer patients treated with adjuvant epirubicin-based dose-dense sequential chemotherapy.Activated HER-receptors in predicting outcome of ER-positive breast cancer patients treated with adjuvant endocrine therapySample parameters affecting the clinical relevance of RNA biomarkers in translational breast cancer research.Potential of ErbB4 antibodies for cancer therapy.HER3 comes of age: new insights into its functions and role in signaling, tumor biology, and cancer therapy.Prognostic significance of HER3 in patients with malignant solid tumors.Association of ErbB1-4 expression in invasive breast cancer with clinicopathological characteristics and prognosis.Exon 8 amplification of epidermal growth factor receptor (EGFR) in invasive breast carcinomas.Comparison of different approaches for assessment of HER2 expression on protein and mRNA level: prediction of chemotherapy response in the neoadjuvant GeparTrio trial (NCT00544765).
P2860
Q24309041-E1CA3EA6-C341-4800-9FDD-0B31E29A40B0Q26864668-E8FE1250-40F5-4091-8055-0317702C9D8EQ27852062-E1DCB8BA-38A8-439F-A60E-35AF7624D8D6Q27853060-A6D399D0-B5B7-4602-B706-C7DA7DE05150Q31134061-4C48D5FD-0CE9-4904-B5BD-323CE362BEA3Q33570512-88955578-66EF-4083-9903-AEB6AB59E229Q33644491-D3901F9C-0CCE-430A-BE67-E6FEBF45D9F1Q33921374-F27FF953-76AC-4A61-8043-1F6D0E159EDFQ34518357-0FF38C3E-A18D-4506-B1DD-17AADC4E402AQ35357793-873D95EE-FAD3-4692-A1BA-3995C21531D4Q35663809-7E082518-DBFC-4D58-AF51-6F35511CADA4Q35744973-EC463CF0-9EC1-457B-8911-F08F8C0E841DQ36223407-7DCD3F9E-FE5A-40AC-8349-F8B49A819964Q36598709-5BE336CC-D108-44AC-AE53-F8848B284D52Q37658764-E7D66CB5-A804-4D36-B4D2-1F7F3BE195DFQ39368710-837120F1-1A34-48B6-A37F-AE298BEA3D90Q42148898-0BF08BA0-8BAF-43B3-ACB0-0C9AE2D65EBAQ54286036-012FEB1D-C4D3-4508-9854-467A025C0674Q54297439-43AEB3E4-40A3-4C51-9789-F31E182289AAQ54395374-BA518C04-105D-4797-90DE-03C6EAFF8BAC
P2860
Evaluation of the prognostic and predictive value of HER family mRNA expression in high-risk early breast cancer: a Hellenic Cooperative Oncology Group (HeCOG) study.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Evaluation of the prognostic a ...... Oncology Group (HeCOG) study.
@en
Evaluation of the prognostic a ...... nic Cooperative Oncology Group
@nl
type
label
Evaluation of the prognostic a ...... Oncology Group (HeCOG) study.
@en
Evaluation of the prognostic a ...... nic Cooperative Oncology Group
@nl
prefLabel
Evaluation of the prognostic a ...... Oncology Group (HeCOG) study.
@en
Evaluation of the prognostic a ...... nic Cooperative Oncology Group
@nl
P2093
P2860
P50
P356
P1476
Evaluation of the prognostic a ...... e Oncology Group (HeCOG) study
@en
P2093
A K Koutras
C Christodoulou
D Pectasides
E Briasoulis
E Timotheadou
G Aravantinos
G Fountzilas
G Zografos
P2860
P2888
P304
P356
10.1038/SJ.BJC.6604769
P407
P577
2008-11-04T00:00:00Z